People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vigil Neuroscience, Inc. | — | Pharmaceuticals | Series C | $215.0M | $1.3B | 2022 |
Christopher Verni at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christopher Verni on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bruce Booth | 1 | 12 |
| Clay Thorp | 1 | 10 |
| Shaan Gandhi | 1 | 4 |
| Stefan Vitorovic | 1 | 3 |
| Mary Thistle | 1 | 2 |
| Cheryl Blanchard | 1 | 2 |
| Jennifer Ziolkowski | 1 | 2 |
| Suzanne Bruhn | 1 | 2 |
| Cheryl Blanchard, Ph. D. | 1 | 1 |
| Gerhard Koenig | 1 | 1 |
| Spyros Papapetropoulos | 1 | 1 |
| Ivana Magovcevic-Liebisch | 1 | 1 |
| Evan Thackaberry | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.